
WHO’s new guidelines support weight-loss drugs from Novo Nordisk, Eli Lilly to treat obesity
Published on: Sept. 17, 2025, 2:34 p.m. | Source: The Financial Express
WHO is set to recommend weight-loss drugs like Wegovy, Ozempic, and Mounjaro for adults with obesity, calling it a serious health condition and suggesting lifestyle changes along with medication.